The TIES platform combines a discreet lid, an enhanced bag system, and connected digital tools, supported by an enabling implant, designed to reduce dependence on continuous pouch wear and give patients more control over daily life.

The TIES port is manufactured from medical-grade titanium using 3D printing technology. The mesh structure is designed to allow tissue integration, creating a stable interface between the body and the external environment. The port is placed during a standard stoma formation procedure or as a secondary procedure.

The element patients use every day. Designed to seal the stoma site interface between emptying. Discreet and low-profile under clothing. Equipped with sensors connected to the OstomySecure digital application for real-time monitoring and patient-clinician communication.
Enhanced emptying system for controlled, on-demand drainage. Designed for discreet daily use, it puts the timing of evacuation back in the hands of the patient. Proprietary interface, built to work with the TIES port.
Collection bag for continuous overnight and extended wear. Designed for hands-free use during sleep and longer stretches between emptying. The same proprietary interface keeps every component locked to the TIES port.
Connected lid with biosensors under development. Mobile app for monitoring. Expected launch: 2027. Regulatory classification: under assessment (may follow Software as Medical Device pathway, separate from TIES implant Class IIb classification under EU MDR).
The enabling technology behind the system. A medical-grade titanium and mesh implant, 3D-printed, that integrates with the body through tissue ingrowth. Placed during standard stoma surgery, it forms the stable interface every patient-facing component connects to.
12 patent families protecting the TIES platform across implant design, accessory interface, digital lid technology, and consumable products. Over 60 national patents granted in major markets including the United States, European Union, United Kingdom, and other key territories.

The TIES port is designed to be placed during standard stoma formation surgery or as a secondary procedure in patients with an existing stoma. The surgical technique involves placement of the titanium mesh port at the stoma site, facilitating tissue integration over time.
OstomySecure AS is seeking EUR 12.5M in equity financing to complete clinical studies, achieve regulatory approvals, and prepare for market launch.